Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

Autor: Penalver, FJ, Marquez, JA, Duran, S, Giraldo, P, Martin, A, Montalban, C, Sancho, JM, Ramirez, MJ, Terol, MJ, Capote, FJ, Gutierrez, A, Sanchez, B, Lopez, A, Salar, A, Rodriguez-Caravaca, G, Canales, M, Caballero, MD, Lopez, JLB, Carbonell, F, Bordas, SF, Lopez, PF, Persona, EP, Guillermo, AL, Martin, RH, Mayans, JR, Palomera, L, Ceballos, EP, Hernandez, JAQ, Grau, RR, de la Cruz, F, Salinas, AS

Publikováno v: Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Cancer medicine
r-FISABIO. Repositorio Institucional de Producción Científica
Cancer Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

Background Consensus is lacking regarding the optimal salvage therapy for patients with follicular lymphoma who relapse after or are refractory to immunochemotherapy. Methods This phase II trial evaluated the efficacy and safety of response-adapted t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::38d0108d847e62c93eac4419133d1794
http://zaguan.unizar.es/record/86474

Telmisartan to prevent recurrent stroke and cardiovascular events

Autor: Yusuf, S, Diener, Hc, Sacco, Rl, Cotton, D, Ounpuu, S, Lawton, Wa, Palesch, Y, Martin, Rh, Albers, Gw, Bath, P, Bornstein, N, Chan, Bp, Chen, St, Cunha, L, Dahlöf, B, DE KEYSER, J, Donnan, Ga, Estol, C, Gorelick, P, Gu, V, Hermansson, K, Hilbrich, L, Kaste, M, Lu, C, Machnig, T, Pais, P, Roberts, R, Skvortsova, V, Teal, P, Toni, Danilo, Vandermaelen, C, Voigt, T, Weber, M, Yoon, Bw, Lembo, Giuseppe, Rasura, Maurizia, Sacchetti, Maria Luisa

Publikováno v: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2008, 359 (12), pp.1225-37. 〈10.1056/NEJMoa0804593〉
New England Journal of Medicine, Massachusetts Medical Society, 2008, 359 (12), pp.1225-37. ⟨10.1056/NEJMoa0804593⟩
New England Journal of Medicine, 359(12), 1225-1237. MASSACHUSETTS MEDICAL SOC

Background: Prolonged lowering of blood pressure after a stroke reduces the risk of recurrent stroke. In addition, inhibition of the renin-angiotensin system in high-risk patients reduces the rate of subsequent cardiovascular events, including stroke

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9ada1720b25d6ae649058a332967a5
https://hal-unilim.archives-ouvertes.fr/hal-00626465

effects of apsirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention regimen for Effectively Avoiding Second Strokes (Profess) trial: a double-bind, active and placebo controled study

Autor: YUSUF, S, DIENER HC, SACCO RL, COTTON D, OUNPUU S, LAWTON WA PALESCH Y. MARTIN RH ALBERS GW, BATH P, BORNSTEIN N, CHAN BP, CHEN ST, CUNHA L, DAHLOF B, DE KEYSER J, DONNAN GA, ESTOL C, GORELICK P, GU V, HERMANSSON K, HILBRICH L, KASTE M, LU C, MACHNIG T, PAIS P, ROBERTS R, SKVORTSOVA V, TEAL P, TONI D, VANDERMAELEN C, VOIGT T, WEBER M, YOON BW, COMI , GIANCARLO

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10495::e98fda351f881b22f20a2fe8d0becad1

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.